|
|
 |
|
|
|
|
Scientific team - Chantale Lessard
MSc (Outcome Research and Pharmacoeconomics)
Chantal Lessard holds a Pharmacy degree and a master’s degree in Pharmaceutical Sciences with specialization in Outcomes Research and Pharmacoeconomics from the Université de Montréal. Currently pursuing a PhD in Public Health at the university’s Faculty of Medicine, her research interests focus on the role of economic evaluation in the decision-making process and its impact on clinical practice.
Ms. Lessard has worked as a clinical research associate in the pharmaceutical industry and as a consultant to other government organizations, such as the Comité de revue de l’utilisation des medicaments (Régie de l’assurance maladie du Québec) and the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). She has been a consulting researcher at AETMIS since 2000.
Recent productions:
Endometrial ablation techniques in the treatment of dysfunctional uterine bleeding[2002-04] - ID: 1068/3222 - Alicia Framarin and Chantale Lessard, AETMIS
Montréal: AETMIS, 2002, xxix-156 pp.
Scientific presentations:
JASP (2002/11/20)
Atelier méthodologique : La production et l’utilisation de méta-analyses et de revues systématiques de la littérature[2004-12] - ID:1789/3295 - Chantale Lessard, AETMIS
ACRSPS / CAHSPR 2004 (2004/05/27)
Life of a report post-publication: Frustrations and satisfactions of HTA researchers[2004-06] - ID: 1327/3577 - Chantale Lessard, AETMIS
ISTAHC 2003 (2003/06/24)
Clinical and economic aspects of the second-generation endometrial ablation techniques in the treatment of dysfunctional uterine bleeding[2003-06] - ID: 1513/3427 - Chantale Lessard, AETMIS
ISPOR 2002, Rotterdam, Les Pays-Bas
Lessard C, Framarin A. Second-generation versus first-generation endometrial ablation techniques in the treatment of dysfunctional bleeding (DUB): a review of the literature [résumé nº PWM3]. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 5th Annual European Congress; du 3 au 5 Novembre 2002; Rotterdam, Pays-Bas. Value Health 2002;5(6):587.
References:
|
|
|
|
|
|
|
